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ABSTRACT
Background Children with acute respiratory tract
infections (ARTIs) receive ≈11.4 million unnecessary
antibiotic prescriptions annually. A noted contributor is
inadequate parent–clinician communication, however,
efforts to reduce overprescribing have only indirectly
targeted communication or been impractical.
Objectives Compare two feasible (higher vs lower
intensity) interventions for enhancing parent–clinician
communication on the rate of inappropriate antibiotic
prescribing.
Design Multisite, parallel group, cluster randomised
comparative effectiveness trial. Data collected between
March 2017 and March 2019.
Setting Academic and private practice outpatient clinics.
Participants Clinicians (n=41, 85% of eligible
approached) and 1599 parent–child dyads (ages 1–5
years with ARTI symptoms, 71% of eligible approached).
Interventions All clinicians received 20 min ARTI
diagnosis and treatment education. Higher intensity
clinicians received an additional 50 min communication
skills training. All parents viewed a 90 second antibiotic
education video.
Main outcome(s) and measure(s) Inappropriate
antibiotic treatment was assessed via blinded medical
record review by study clinicians and a priori defined
as prescriptions for the wrong diagnosis or use of the
wrong agent. Secondary outcomes were revisits, adverse
drug reactions (both assessed 2 weeks after the visit)
and parent ratings of provider communication, shared
decision-making and visit satisfaction (assessed at end of
the visit on Likert-type scales).
Results Most clinicians completed the study (n=38,
93%), were doctors (n=25, 66%), female (n=30, 78%)
and averaged 8 years in practice. All parent–child dyad
provided data for the main outcome (n=855 (54%)
male, n=1043 (53%) <2 years). Inappropriate antibiotic
prescribing was similar among patients who consulted
with a higher intensity (54/696, 7.8%) versus a lower
intensity (85/904, 9.4%) clinician. A generalised linear
mixed effect regression model (adjusted for the two-
stage nested design, clinician type, clinic setting and
clinician experience) revealed that the odds of receiving
inappropriate antibiotic treatment did not significantly
vary by group (AOR 0.99, 95% CI: 0.52 to 1.89, p=0.98).
Secondary outcomes of revisits and adverse reactions did

STRENGTHS AND LIMITATIONS OF THIS STUDY
⇒ Large number of clinicians and parent–child dyads

engaged.
⇒ Feasible interventions modelled on prior successful

interventions.
⇒ Rigorous methods conducted in real world clinical

settings.
⇒ Lack of a control group or baseline antibiotic pre-

scribing information.

not vary between arms, and parent ratings of satisfaction
with quality of parent–provider communication (5/5),
shared decision making (9/10) and visit satisfaction (5/5)
were similarly high in both arms.
Conclusions and relevance Rate of inappropriate
prescribing was low in both arms. Clinician education
coupled with parent education may be sufficient to yield
low inappropriate antibiotic prescribing rates. The absence
of a significant difference between groups indicates that
communication principles previously thought to drive
inappropriate prescribing may need to be re-examined or
may not have as much of an impact in practices where
prescribing has improved in recent years.
Trial registration number NCT03037112.

In the USA, most antibiotic prescribing occurs
in the outpatient setting1 where children with
acute respiratory tract infections (ARTIs)
receive 34 million antibiotic prescriptions
annually.2 Estimates indicate that at least 29%
of these prescriptions are unnecessary.3
Antibiotic prescribing behaviour is a
complex and multifaceted process, but the
communication between parents or legal
guardians (hereafter referred to as parents)
and clinicians is central. Clinicians cite strong
parent demand as a major cause of inappropriate prescribing.4–7 Clinicians often capitulate to this perceived pressure because they
do not want parents/patients to leave ‘empty-
handed’,8–10 fear receiving poor encounter
satisfaction scores from parents,11 and/or
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view explaining why antibiotics are not necessary as time-
consuming and unrewarding.8 9
Efforts to reduce inappropriate antibiotic prescribing
in the paediatric setting have typically taken the form of
educational interventions to increase antibiotic knowledge among clinicians and/or parents, electronic decision support systems and/or behavioural interventions
informed by behavioural economics and psychological
science.12–15 Many have been successful, with those that
target parent–clinician communication and simultaneously intervene on parents and clinicians evidencing the
strongest results.13 Of the communication interventions
tested, only one has directly targeted clinicians’ perceptions of parental expectations for antibiotics alongside
antibiotic education and shared decision-
making.16
This UK-based study provided intensive communication
training for clinicians and a multipage patient–clinician
interactive educational booklet to enhance shared decision making. Clinicians in the intervention arm demonstrated statistically and clinically significant reductions in
antibiotic prescribing as compared with control clinicians.
While impactful, the intervention was viewed impractical
for most real-world settings.17
Effective interventions that are efficacious and feasible
in routine outpatient paediatric care in the USA are
lacking. Using the Francis et al16 intervention as our
model, we sought to: (1) develop a version of this efficacious intervention that would enhance parent–clinician communication while being feasible in ambulatory
paediatric care and (2) compare it to a feasible educational intervention on the rate of inappropriate antibiotic
prescribing.

METHODS
Study overview
This was a multisite, parallel group, cluster randomised
comparative effectiveness trial conducted in two paediatric outpatient clinics, with clinicians randomised (1:1)
to a higher intensity intervention (prescribing education
and communication skills training) or a lower intensity
intervention (prescribing education only). Parent–child
dyads enrolled in the study were exposed to either intervention according to the clinician who conducting their
clinic visit. We hypothesised that compared with parent–
child dyads managed by clinicians randomised to the
lower intensity intervention, parent–child dyads managed
by clinicians randomised to the higher intensity intervention would evidence lower rates of inappropriate antibiotic prescriptions (see protocol paper for additional
details).18
Patient and public involvement
In the early planning stages for this study, we conducted
focus groups and individual interviews with clinical,
parent, payer and community stakeholders to assess the
viability and inform the design of the study. We then
recruited a parent research associate who became a core
2

member of our research team, attended all study meetings and co-led our community advisory board (CAB).
Our CAB was composed of 15 parent, provider and
community stakeholders and was diverse (ie, 3 males, 7
Latinx (3 exclusively Spanish speaking) and 3 African
American members). CAB meetings occurred regularly
throughout the study. All aspect of the study design,
settings, participant burden, materials, procedures,
interpretation of data and dissemination of study findings were informed by the CAB and community research
associate. Study results were disseminated to all clinic
providers. A parent summary of findings will be provided
to study sites to share with parents after this paper is
published.
Study setting
The study was conducted at an academic medical facility
(CMH Primary Care Clinics) in Kansas City, Missouri,
USA and both locations of a private practice (Heartland
Primary Care) in Kansas City and Lenexa, Kansas, USA.
Participants
Clinicians
All clinicians at both clinics were screened for eligibility.
Inclusion criteria were being a paediatrician (medical
doctor (MD) or doctor of osteopathic medicine (DO)) or
nurse practitioner (certified paediatric nurse practitioner
(CPNP) or advanced practice registered nurse (APRN))
and actively and independently conducting consultations with our target population. Eligible clinicians were
recruited during study orientation sessions, where interested clinicians completed informed consent and were
given a sealed envelope prepared by the study statistician
that contained their group assignment. Clinicians were
stratified by patient volume and clinic.
Parent–child dyads
Parent–child dyads were recruited from March 2017
to March 2019. Study staff prescreened all potentially
eligible parent–child dyads and provided a study flyer
during check-in. Interested dyads were given information
about the study and offered eligibility screening. If more
than one caregiver was present, they were asked to designate one person who would independently complete
the written informed consent and all assessments. Clinicians had no role in identifying potentially eligible dyads,
screening, consenting or data collection. Clinic staff who
scheduled patients’ appointments were blinded to clinician randomisation. Dyads were eligible if the patient
was between ages 1 and 5 years, had ARTI symptoms and
his/her parent was fluent in English or Spanish.18 Children were not eligible if they had received an antibiotic
in the last 30 days, had a concurrent probable bacterial
non-respiratory infection, known immunocompromising
conditions, complex chronic care condition,19 required
hospitalisation during the visit or had previously participated in the study.
Goggin K, et al. BMJ Open 2022;12:e049258. doi:10.1136/bmjopen-2021-049258
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Table 1 Diagnostic criteria for bacterial acute respiratory tract infections (ARTIs) and appropriate antibiotic selection
Bacterial
ARTI

Primary
antibiotic

Diagnostic criteria

Acute Otitis
1. Fever ≥38.3°C with either A or B:
Media
A. Moderate to severe bulging of tympanic membrane on exam, or
(either criteria)
B. Mild bulging of TM and recent (<48 hours) onset of ear pain
2. New onset of otorrhea not due to acute otitis externa
Sinusitis
(any of the
three criteria)

Secondary antibiotics for penicillin
allergy

Amoxicillin Cefdinir, cefpodoxime, ceftriaxone,
cefuroxime, clindamycin

1. Daytime cough or nasal discharge for greater than 10 days
Amoxicillin Cefdinir, cefpodoxime, cefuroxime,
2. High fever (>39°C) with purulent nasal discharge or facial pain lasting
clindamycin
three consecutive days at the beginning of the illness
3. Worsening signs or symptoms characterised by the new onset of fever,
headache, or increase in nasal discharge following a typical viral URI

Community
1. Fever, tachypnoea and focal findings on pulmonary exam
acquired
2. (A) Fever, (B) Tachypnoea, cough or retractions and (C) chest
Pneumonia
radiograph consistent with a focal consolidation
(either criteria)

Amoxicillin Cefpodoxime, cefprozil, cefuroxime,
clindamycin

Streptococcal 1. Fever, pharyngitis and positive rapid streptococcal antigen test or
pharyngitis
culture
(both criteria) 2. Lack of viral signs and symptoms

Amoxicillin Cephalexin (preferred unless previous
type I hypersensitivity reaction to
penicillin) clindamycin, azithromycin

TM, tympanic membrane; URI, upper respiratory infection.

Intervention components and description of arms
Parent video
The 90 s video used gain-framed messages20 21 to explain
when antibiotics are and are not indicated while emphasising the risk of side effects and resistant organisms.
Research has shown that people react to the same
trade-
off in different ways depending on whether the
possible outcomes are presented as losses or gains.20 We
tailored all parent materials to highlight the gains of not
using antibiotics (eg, staying safe from side effects) that
might increase parents’ comfort with not getting an antibiotic prescription for their child. The video also highlighted information that clinicians should provide (eg,
estimate of illness duration, recommendations for system
relief) during a visit. The video was successful in reducing
parents’ interest in obtaining an antibiotic for their child,
especially among those with higher baseline interest.22

trainings for all study clinicians were provided twice
during the study.
Clinician communication skills training
The in-
person, 50 min communication skills training
provided by the study’s behavioural psychologist (KG)
used didactic and interactive learning strategies, including
viewing/discussing motivational role model videos. The
goal was to enhance clinicians’ skills and confidence in
the use of proven parent-centred communication strategies and the parent educational trifold brochure (see
protocol paper for additional details).18 Clinicians were
also trained to consider parents’ ratings of their interest
in obtaining antibiotics after viewed the video.

Parent educational trifold brochure
The inside of the brochure provided ‘gain-framed’ information about when antibiotics are and are not necessary
and the risks involved in taking antibiotics. The outside
of the brochure included a place to write the child’s first
name and parent tips for communicating with clinicians.
It also included check boxes for the clinician to indicate
the diagnosis, if antibiotics were needed, recommended
home care treatments and expected recovery time.

Lower intensity intervention
This intervention was modelled on proven parent-focused
and clinician-
focused educational interventions.13 23
Clinicians completed the general antibiotic education
described above.
In exam rooms prior to the consultation, parents who
saw a clinician trained in the Lower Intensity intervention completed the baseline survey, saw the video and the
inside of the parent brochure, and rated their desire for
antibiotics all via a tablet computer. They did not receive
a hard copy of the study brochure and their interest in an
antibiotic rating was not shared with their clinician.

Clinician general antibiotic education
Using didactic and interactive learning strategies, study
physicians (AM and JGN) provided a 20 min, in-person
general antibiotic education training on diagnosis and
treatment of ARTI. The training covered pros and cons
of antibiotics, impact of inappropriate use, Centers for
Disease Control and Prevention antibiotic prescribing
guidelines, common reasons for antibiotic misuse and
viewing/discussing the 90 s parent video. Refresher

Higher intensity intervention
The higher intensity, Let’s Talk About Antibiotics, intervention was informed by a series of evidence-
based
interventions conducted in the UK and Europe,16 24–29
Clinicians randomised to this arm completed the general
antibiotic education and communication skills training
described above. Before meeting with dyads, clinicians
in this arm were provided with parents’ ratings of their
interest in obtaining antibiotics after watching the parent
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Figure 1

Parent–child dyads enrolment.

video via a sticky note on the exam room door. To assess
fidelity to the communication skills and check for contamination between arms, a subsample of all visits (10%) were
audio recorded and objectively coded by blinded raters
using established methods.30 31
In exam rooms prior to the consultation, parents who
saw a clinician trained in the higher intensity intervention completed the baseline survey, saw the video and
the inside of the parent brochure, rated their desire for
antibiotics via a tablet computer and received a personalised (child’s name written in) hard copy of the study
brochure.
Strategies to reduce the risk of contamination
We employed several strategies to reduce the likelihood
of contamination between study arms. Specifically, we (1)
designed intervention components to not be easily transferred between clinicians (eg, the brochure was distributed by study staff to ensure that only parents who were
consulted by clinicians in the Higher Intensity arm receive
them), (2) ensured that all communication (written or in
4

person) with clinicians in the lower intensity arm did not
reveal any of the strategies from the higher intensity arm,
(3) reviewed the importance of keeping intervention
arms distinct during clinician training and asked higher
intensity clinicians to pledge not to share any details or
materials with their colleagues randomised to the lower
intensity arm and (4) trained higher intensity arm clinicians in communication strategies for dealing with lower
intensity arm colleagues who ask for more information.
Primary outcome
The primary outcome was rate of inappropriate antibiotic
prescribing (ie, number of patients receiving an inappropriate prescription/number of patients in arm). Inappropriate prescribing was assessed by blinded study physicians
(AM and JGN) who reviewed the medical record documentation for each patient. Prescriptions were considered inappropriate if they were, prescribed: (1) for a viral
ARTI, (2) for a presumed bacterial ARTI that does not
meet table 1 criteria, (3) broad-spectrum antibiotic for
a bacterial ARTI in a child without a penicillin allergy or
Goggin K, et al. BMJ Open 2022;12:e049258. doi:10.1136/bmjopen-2021-049258
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Table 2 Parent and patient demographics (N=1599)
Higher
intensity
Gender of parent
 Female

Lower
intensity

584 (83.9%) 764 (84.6%)

Ethnicity of parent
 Hispanic

129 (18.5%) 171 (18.9%)

Race of parent
 Asian

13 (1.9%)

10 (1.1%)

 Black

90 (12.9%)

104 (11.5%)

 White

537 (77.2%) 721 (79.8%)

 Multiracial

15 (2.2%)

24 (2.7%)

 Other

10 (1.4%)

13 (1.4%)

 Chose not to answer

31 (4.5%)

31 (3.4%)

41 (5.9%)

60 (6.6%)

 Less than high school

38 (5.5%)

49 (5.4%)

 High school degree or GED

151 (21.7%) 183 (20.3%)

 Some college

228 (32.8%) 335 (37.1%)

 Secondary degree

196 (28.2%) 240 (26.6%)

 Postsecondary degree

79 (11.4%)

94 (10.4%)

 Other/unknown

4 (0.6%)

2 (0.2%)

Preferred language
 Spanish
Education

Patient age
 1

249 (35.8%) 307 (34.0%)

 2

126 (18.1%) 172 (19.0%)

 3

104 (14.9%) 145 (16.1%)

 4

96 (13.8%)

 5

121 (17.4%) 143 (15.8%)

136 (15.1%)

Patient sex
 Female

327 (47.1%) 414 (45.9%)

 Male

367 (52.9%) 488 (54.1%)

Patient diagnosis
 Viral URI/pharyngitis/OME

352 (50.6%) 440 (48.7%)

 Strep throat

20 (2.9%)

 AOM

126 (18.1%) 162 (17.9%)

 Sinusitis

2 (0.3%)

 Pneumonia
 Multiple or other diagnosis

6 (0.9%)
13 (1.4%)
190 (27.3%) 268 (29.7%)

16 (1.8%)
4 (0.4%)

AOM, acute otitis media; GED, General Educational Development
Test; OME, otitis media with effusion; URI, upper respiratory
infection.

(4) non-recommended alternative antibiotic for a bacterial ARTI (see table 1) in a child with a penicillin allergy.
To guard against the potential for clinicians to use
diagnostic codes to support their antibiotic prescribing,7
study physicians reviewed detailed symptoms, physical
examination findings and diagnostic tests to assess the
Goggin K, et al. BMJ Open 2022;12:e049258. doi:10.1136/bmjopen-2021-049258

appropriateness of the patient’s diagnosis. Ten per cent
of all chart reviews were verified by the other study physician blinded to the initial coding, inconsistencies were
reconciled.
Secondary outcomes
Data on revisits and adverse drug reactions were collected
via follow-up phone calls with parents 2 weeks after the
visit. Revisits were assessed by asking parents if they sought
any additional treatment for their child for the same
symptoms or complications from any treatment provided
in the initial visit. Side effects and adverse drug reactions
were assessed if antibiotics were prescribed.
Shared decision-
making was assessed immediately
following the visit using an adapted version of the three-
item CollaboRATE questionnaire.32 Parents rated How
much effort was made to: (1) help you understand your
child’s health issue?; (2) listen to the things that matter
most to you about your child’s health issues? and (3)
include what matters most to you in choosing what to
do next? on a 10-point response scale ranging from ‘no
effort was made’ to ‘every effort was made.’ The scale’s
psychometric properties have been established.33
Quality of parent–clinician communication was assessed
immediately following the visit with the question, ‘How
satisfied were you with the communication between you
and your child’s healthcare clinician?’ Overall visit satisfaction was assessed with the question, ‘Overall, how satisfied were you with the visit?’ Both items were scored on
a five-point scale ranging from ‘very dissatisfied’ to ‘very
satisfied’.
Analyses
All analyses were conducted using an intention-to-treat
strategy. We constructed a two-stage nested design, with
parents nested within clinicians (level-1 units) and study
site (level-2 units) generalised linear mixed-effect regression models (GLMM) to assess the impact of intervention type on our primary outcome of inappropriate
antibiotic prescribing using Stata.34 Alternative covariance structures were investigated, but as hypothesised,
the exchangeable structure was sufficient. We employed
robust standard errors to help minimise misspecification and examine time as a potential random effect.
We examined the effects of the potential prespecified
covariates on the outcomes with the goal of identifying
the most parsimonious final models and we explored
the heterogeneity of treatment effect. Variables considered included: clinic, clinician type, years of experience, patient age and sex, parent education level, race/
ethnicity, preferred language, relationship to patient and
insurance type. We created a binary indicator for each
variable and included each as an interaction term in a
separate regression model. We examined these interaction terms across intervention arms and explored within-arm differential trends in our primary and secondary
outcomes over time.
5
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Sample size calculation and power
Prior research examining our primary outcome showed
30% of the antibiotics prescribed in the outpatient
ARTI visits were inappropriate.3 35 Prior intervention
studies produced 20%–81% reductions in inappropriate
prescribing.36 37 Based on the intraclass correlation coefficient (ICC) observed in the Meeker et al study,37 we
assume an ICC of 0.04. With 40 clinicians, α of 0.05 and
80% power, we estimated that a sample size of 760 per
arm would be needed to detect a 9% difference between
arms. Allowing for an attrition rate of 5%, we aimed to
recruit 1600 participants to ensure adequate power.
RESULTS
Clinicians
All clinicians at both sites (N=51) were voluntarily screened
for eligibility; five were ineligible, four failed to respond
after multiple contacts and one declined to enrol in the
study. All 41 clinicians enrolled (22 (54%) randomised to
the higher intensity arm; 19 (46%) randomised to lower
intensity arm) conducted clinic visits with enrolled participants. Three clinicians (all in the higher intensity arm)
left their practices during the study, leaving 38 clinicians
who all completed the follow-up survey and interview.
Most clinicians were female (n=30, 78%) and MD/DO
physicians (n=25, 66%) with 8 median years in practice
(IQR 4–14; range 1–40). Clinician demographics were
similar across arms and between those who did and did
not participate in the study.
Parent–child dyads
Figure 1 illustrates the flow of parent–child dyads from
prescreening through the 2-week follow-up visit. Table 2
displays demographics for the 1599 dyads included in the
primary analysis. Demographic characteristics of parents
and children were similar among those exposed to the
higher or lower intensity intervention. Spanish-speaking
parents and those who had more education were more
likely to complete the 2-
week assessment, no other

differences were observed. Missing survey responses were
rare overall (<1% for all variables) and did not exhibit
any systematic patterns so we did not impute values.
Fidelity assessment
Analysis of 141 visit audio recordings confirmed a similar
mean duration of visits (higher=11.7 vs lower=10.2 min)
and no evidence of contamination between arms.
Compared with lower intensity clinicians, higher intensity
clinicians consistently delivered more of the communication content they were taught in training and no higher
intensity materials were used in sessions conducted by
lower intensity clinicians.
Primary outcome: inappropriate antibiotic prescribing
A total of 429 (26.8%) patients received an antibiotic
prescription with 139 (32.4%) meeting criteria for being
inappropriate (table 3). The most common reasons for
an antibiotic to be considered inappropriate were being
prescribed for a presumed bacterial ARTI that did not
meet diagnostic criteria (n=109; 78.4%) and prescribing
a broad-spectrum antibiotic for a child without a penicillin allergy (n=24; 17.3%). The rate of inappropriate
prescriptions among all enrolled patients in each arm
was similar among higher intensity (54 of 696; 7.8%) and
lower intensity (85 of 903; 9.4%) clinicians. Inappropriate
antibiotic prescribing also did not vary significantly based
on study site or clinician type. In the unadjusted GLMM,
we found that the odds of receiving inappropriate antibiotic treatment for the higher intensity arm did not vary
significantly when compared with the lower intensity arm
(OR 1.09; 95% CI 0.56 to 2.10; ICC=0.11; table 4).
Heterogeneity of treatment effect
After adjusting for clinician type, clinic setting and clinician experience, there was still no significant intervention
effect (Adjusted Odds Ratio (AOR) 0.99; 95% CI 0.52 to
1.89). However, the interaction of the treatment arm and
clinician type was significant in the adjusted GLMM model
(AOR 0.12; 95% CI 0.04 to 0.37; see online supplemental

Table 3 χ2 comparison of overall and inappropriate antibiotic prescribing (N=1599)
Any antibiotic prescribed
n

Freq (%)

Study arm
 Higher

696

 Lower

Inappropriate antibiotic prescribed
n

Freq (%)

196 (28.2)

696

54 (7.8)

903

233 (25.8)

903

85 (9.4)

 Private practice

1292

350 (27.1)

1292

109 (8.4)

 Academic

307

79 (25.7)

307

30 (9.8)

0.291

Site

0.455

0.129
907
692

230 (25.4)
199 (28.8)

P value
0.244

0.630

Clinician type
 MD/DO
 CPNP/APRN

P value

0.572
907
692

82 (9.0)
57 (8.2)

APRN, advanced practice registered nurse; CPNP, certified paediatric nurse practitioner; MD/DO, medical doctor/doctor of osteopathic.
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Table 4 ORs of receiving inappropriate antibiotic (N=1599)
Unadjusted

Adjusted*

95% CI

95% CI

OR

Lower

Upper

P value

OR

Lower

Upper

P value

1.09

0.56

2.10

0.81

0.99

0.52

1.89

0.98

1.24

0.63

2.44

0.53

1.29

0.67

2.46

0.45

 Academic (vs private)

1.21

0.63

2.30

0.56

1.13

0.60

2.16

0.70

Clinician years of experience
 10+ years (vs <10 years)

1.40

0.73

2.66

0.31

1.42

0.73

2.77

0.30

Intervention arm
 Higher intensity (vs lower)
Clinician type
 CPNP/APRN (vs MD/DO)
Practice type

*Adjusting for intervention arm, clinician type, practice type and clinician years of experience.
APRN, advanced practice registered nurse; CPNP, certified paediatric nurse practitioner; MD/OD, medical doctor/doctor of osteopathic.

table 1). Specifically, the MD/DO clinicians in the higher
intensity intervention were less likely to prescribe an inappropriate antibiotic than MD/DO clinicians in the lower
intensity intervention arm. The reverse was true for the
CPNP/APRN clinicians. No interaction between intervention and gender or location was observed. No interaction between treatment and any of the parent–patient
dyad variables (ie, patient age or sex, parent education
level, race/ethnicity, preferred language, relationship to
patient or insurance type) was observed.
Secondary outcomes
Revisits and adverse drug reactions: Approximately 12%
of patients had a return visit within 2 weeks of their index
visit. The rate of revisits did not vary between patients seen
by higher or lower intensity clinicians (12.2% vs 11.9%,
p=0.879). Adverse reactions to the prescribed antibiotic
were similar across arms (16.5% vs 12.8%, p=0.27). (Antibiotic prescription rates for different ARTI diagnoses are
presented by arm in online supplemental table 2).
Shared decision-making: Parents’ CollaboRATE ratings
were extremely high overall (likely evidencing a ceiling
effect) and similar across higher and lower intensity arms
(median 9.0 (IQR: 8.7–9.0) vs 9.0 (IQR: 8.3–9.0), p=0.85).
Quality of parent–clinician communication and visit
satisfaction: Parent rated satisfaction with their clinician’s
communication during the visit (median 5 (IQR: 5–5) vs
5 (IQR: 5–5), p=0.20) and their overall visit satisfaction
(median 5 (IQR: 5–5) vs 5 (IQR: 5–5), p=0.38) were also
very high overall and similar between arms.
Clinician satisfaction and feasibility
Most clinicians (84%) reported being ‘very satisfied’ with
the programme, thought it would be ‘very’ (71%) effective in reducing inappropriate prescribing and all would
recommend it to other clinicians.
Parent satisfaction
week
The majority of parents who completed the 2-
follow-up survey (n=1337) reported being ‘very’ (92%)
Goggin K, et al. BMJ Open 2022;12:e049258. doi:10.1136/bmjopen-2021-049258

satisfied with the programme and 93% reported that they
would recommend it to others.

DISCUSSION
This randomised comparative effectiveness trial
comparing two feasible interventions for enhancing
parent–clinician communication found no evidence of a
difference in inappropriate antibiotic prescriptions. Inappropriate antibiotic prescribing was lower than recently
published estimates of inappropriate prescribing in the
US Midwest (14.3%),38 which have been on the decline,
especially among paediatricians.39 Nevertheless, it was
still higher than findings from other successful intervention studies (rates from 1.5% to 3.9%).15 40 In the main
outcome analysis, the odds of receiving an inappropriate
antibiotic did not vary significantly between the higher
and lower intensity arms, even after adjusting for clinician
type, clinic setting and clinician experience.
Secondary outcomes of revisits and adverse reactions did not vary between patients seen by higher
or lower intensity clinicians. These findings indicate
that there is no evidence that one of the interventions
presented a greater risk to patients than the other.
Parent ratings of shared decision making, satisfaction with quality of parent–clinician communication
and visit satisfaction were all very high and similar
between arms. Ceiling effects on the measures were
apparent and likely reduced our ability to observe any
true differences between arms. Nevertheless, these
findings indicate that both interventions were highly
satisfactory to parents.
In this study, higher intensity MD/DO clinicians
were significantly less likely to prescribe inappropriate antibiotics than their MD/DO counterparts in
the lower intensity arm. The reverse was true for the
CPNP/APRN clinicians. The reasons for this difference among MD/DO clinicians are unclear and we
likely have too few CPNP/APRN clinicians to draw any
7
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definitive conclusions about this subgroup, but there
are data to support the notion that CPNP/APRN are
simply more likely to adhere to guidelines41 so the
educational training provided in both arms was likely
sufficient to ensure similar low rates of inappropriate
prescribing among CPNP/APRNs. Future studies
should continue to explore difference in response to
intervention between different types of clinicians.
The lack of a statistically significant or clinically
meaningful main effect may indicate that shared
decision-m aking and the other communication factors
targeted by the higher intensity intervention were not
as strongly related to inappropriate prescribing as
had been expected. This may indicate a cultural shift
in parental expectations and/or clinician comfort
in withholding unnecessary antibiotics, challenging
the relevance of early literature to the social and
communication dynamics at play today. It may be
that the antibiotic education training for clinicians in
both arms and study video that significantly reduced
parents’ desires for an antibiotic 22 might have been
enough to make a meaningful impact on prescribing.
Other recent studies have found success focusing
on clinician education about appropriate antibiotic
prescribing and the effects of peer comparison. 37 40
Clinician education interventions may be sufficient
to yield long-term benefits, as parental expectations
for antibiotics continue to decrease from an overall
cultural shift or from exposure to a high-
quality
parent education video like the one used in this study.
Limitations
The overall low rate of inappropriate antibiotic prescribing
across interventions and sites is encouraging, but our
design did not allow us to draw conclusions about the role
of either intervention in these lower rates compared with
usual care. Future studies should target settings with high
rates of inappropriate prescribing. Higher intensity intervention clinicians may not have been given a sufficient
‘dose’ of the training. Lack of a control group or baseline
antibiotic prescribing information limits our ability to
understand how the rates of inappropriate prescribing we
observed in the two intervention arms differs from usual
practice at the study sites.
CONCLUSION
Implementing evidence-
based clinician and parent
interventions to improve antibiotic prescribing can be
acceptable to clinicians and parents and feasible in both
academic and private paediatric outpatient settings. Clinician education coupled with high-quality parent education delivered via video may be sufficient to yield low
inappropriate antibiotic prescribing rates.
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Supplemental Table 1: Regression Analyses of Treatment Arm Interaction.

Treatment Arm Interaction Term
Site (ref= private practice)
Clinical type (ref= CPNP/APRN)
Clinical years of experience (ref= <10 years)
Parent preferred language (ref= English)

OR
1.73
0.13
0.61
1.09

UNADJUSTED
95% Confidence
Interval
p-value
Lower
Upper
0.404
0.001
0.462
0.906

0.48
0.04
0.16
0.25

6.25
0.44
2.27
4.89

OR
1.87
0.12
0.66
1.13

ADJUSTED
95% Confidence
Interval
p-value
Lower
Upper
0.325
<0.001
0.543
0.871

0.54
0.04
0.18
0.25

6.53
0.37
2.49
5.03
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Supplemental Table 2: Antibiotic Prescription Rates for Different ARTI Diagnoses by Arm.

Lower Intensity
Denom Treated
Provider Diagnosis
Viral URI
Pharyngitis
Strep
Throat
AOM
OME
Sinusitis
Pneumonia
2+
Diagnoses
Other Dx

Higher Intensity

%
Treated

Denom Treated

%
Treated

376
51

4
5

1.1%
9.8%

317
26

0
1

0.0%
3.8%

16
162
13
4
14

16
157
0
4
14

100.0%
96.9%
0.0%
100.0%
100.0%

20
126
9
2
6

17
125
3
2
6

85.0%
99.2%
33.3%
100.0%
100.0%

58
210

33
1

56.9%
0.5%

68
122

40
2

58.8%
1.6%

904

234

25.9%

696

196

28.2%
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